Multiple sclerosis. Multiple sclerosis
Conditions
Interventions
Intervention 1: one 10 mg Riboflavin capsul per day, oral, for 6 mounts. Intervention 2: placebo: lactos, one capsul per day, for 6 mounts.
Treatment - Drugs
one 10 mg Riboflavin capsul per day, oral, for 6 mounts
placebo: lactos, one capsul per day, for 6 mounts
Sponsors
Ahvaz Jondishapour University of Medical Sciences
ACECR-Khuzestan
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. Tha approvment of MS disease by MS committee, 2. the age between 18-50 years old, 3. the patient should not decide to change or start disease regulation or symptomatic treatments, 4. using brrietric trice for females in productivity age. exclusion criteria: 1. gestation, 2. intake other vitmins contemporary with riboflavin, 3. contributing in another trials contemporary, 4. the ages under 18 and upper 50 years old.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Homosystein serum levels. Timepoint: 6 mounts. Method of measurement: Biochemical test.;Erythrocyte glutathion reductse activity coefficients. Timepoint: 6 mounts. Method of measurement: Biochemical test. | — |
Secondary
| Measure | Time frame |
|---|---|
| EDSS. Timepoint: 6 mounts. Method of measurement: questionnaire.;Quality of life scores. Timepoint: 3 mounts. Method of measurement: MSQOL questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMiss Kushki
Khuzestan Multiple Sclerosis Society Office
Outcome results
None listed